Overview and Scope
Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.
Sizing and Forecast
The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $27.91 billion in 2023 to $31.11 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased research and development (r&d) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support.
The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $47.21 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Segmentation & Regional Insights
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In vitro diagnostics(IVD)
Top Major Players
ABB Ltd.
Schneider Electric SE
Eaton Corporation PLC
Larsen & Toubro Ltd.
Siemens AG
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2023. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
Major Driver Impacting Market Growth
The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, according to the American Association for Clinical Chemistry (AACC), a US-based scientific and medical professional organization, more than 200,000 laboratories certified under the Clinical Laboratory Improvement Amendment (CLIA) execute almost 13 billion laboratory tests in the US each year, and laboratory services comprise 2.3% of U.S. healthcare expenditures and two percent of Medicare expenditures. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules market.
Key Industry Players
Major companies operating in the non-therapeutic biomolecules market report are ABB Ltd., Schneider Electric SE, Eaton Corporation plc, Larsen & Toubro Ltd., Siemens AG, LS Electric Co. Ltd, Entec Electric & Electronic Co. Ltd, EPE Switchgear (M) Sdn. Bhd, Lucy Electric Ltd., Ormazabal Corporación Empresarial S.L., Crompton Greaves Consumer Electricals Limited, Orecco Electric d.o.o, Alfanar Group Ltd., LSIS Co.Ltd., Toshiba Corp., CG Power & Industrial Solutions Ltd., SwitchGear Company NV, NOJA Power Switchgear Pty Ltd., G&W Electric Company, C&S Electric Limited, E+I Engineering Ltd., Hawker Siddeley Switchgear Ltd., Kappa Engineering (Pty) Ltd., KONČAR – Electrical Industry Inc., Laxmi Electronics Pvt. Ltd., MGC Moser-Glaser AG, Mors Smitt B.V, Nissin Electric Co. Ltd., RPS Switchgear Limited, S&S Power Switchgear Limited, Slaters Electricals Ltd., Switchgear Power Systems LLC, Tavrida Electric AG, TE Connectivity Ltd., TGOOD Global Ltd., Trayer Engineering Corporation, VEO Oy, Wahah Electric Supply Company of Saudi Arabia Co., Xiamen Huadian Switchgear Co. Ltd.
The non-therapeutic biomolecules market report table of contents includes:
1. Executive Summary
2. Non-Therapeutic Biomolecules Market Characteristics
3. Non-Therapeutic Biomolecules Market Trends And Strategies
4. Non-Therapeutic Biomolecules Market – Macro Economic Scenario
5. Global Non-Therapeutic Biomolecules Market Size and Growth
……………………….
31. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking
32. Global Non-Therapeutic Biomolecules Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market
34. Non-Therapeutic Biomolecules Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
